Concepedia

Yinglu Zhou

YZ

11

Publications

543

Citations

10

H-Index

2017

Active since

Affiliations

Duke University(Current)

Dana-Farber Cancer Institute

Duke Medical Center

Harvard University

Qingdao Agricultural University

Yinglu Zhou is an author at Duke University specializing in medicine, cell biology, and molecular signaling.

ORCID

Top concepts

Publications per year

2017–2024

11

Publications

11

Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance

Su Deng, Choushi Wang, Yunguan Wang et al. · Nature Cancer · 2022 · 138 citations · Full text

, , +18

Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer

Yanjing Li, Yiping He, William Butler et al. · Science Translational Medicine · 2019 · 135 citations · Full text

Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance

Aishath Naeem, Filippo Utro, Qing Wang et al. · Blood Advances · 2022 · 74 citations · Full text

Cytotoxic and chemosensitization effects of Scutellarin from traditional Chinese herb Scutellaria altissima L. in human prostate cancer cells

Chen Gao, Yinglu Zhou, Zhongling Jiang et al. · Oncology Reports · 2017 · 58 citations · Full text

, , +18

Antitumor effects of baicalin on ovarian cancer cells through induction of cell apoptosis and inhibition of cell migration in vitro

Chen Gao, Yinglu Zhou, Huatao Li et al. · Molecular Medicine Reports · 2017 · 50 citations · Full text

, , +15

Rows per page

1–5 of 11